LSBio: Acquires Absolute Antibody Ltd.

  • SEATTLE–(BUSINESS WIRE)–LSBio (LSBio™), pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast
  • Terms of the transaction were not disclosed
  • LSBio also provides IHC-validated reagent antibodies and services to the global community of academic, pharmaceutical, and biotech researchers
  • The Company has built a catalog of more than 750,000 reagent antibodies, assay kits, proteins, and biochemicals, and its acquisition of Absolute Antibody and Kerafast
  • The new acquisition combines a strong recombinant antibody portfolio with LSBio’s expertise in application-specific validation to make sequence-defined
  • The acquisition marks the latest investment by LSBio to rapidly build its product portfolio
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Santander Tightens Operations with Closure of 44 More Branches

The bank continues its restructuring as customer preferences shift to digital banking.Highlights: Santander is closing 44 more branches...

Stablecoin Bank Kontigo Suffers Cyber Attack, Disrupting Operations

The cyber incident raises concerns about security in fintech.Highlights: Kontigo, a prominent stablecoin bank, experienced a cyber attack.The...

Universal Launches UAE’s First Central Bank Registered Stablecoin

The new digital currency aims to enhance financial transactions in the UAE.Highlights: Universal launched the UAE's first Central...

Mastercard Launches BIN Sponsorship Programme for UK Fintechs

New initiative aims to support fintech innovation in the UK market.Highlights: Mastercard unveils BIN sponsorship programme for UK...